Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  The Hillside journal of clinical psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 2820854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Damage to N-methyl D-aspartate receptors following perinatal hypoxia-ischemia and its relation to schizophrenia

  2025cites this paper
• Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

  2025cites this paper
• A New Three-Hit Mouse Model of Neurodevelopmental Disorder with Cognitive Impairments and Persistent Sociability Deficits

  2024cites this paper
• NMDAR dysfunction and the regulation of dopaminergic transmission in schizophrenia.

  2024cites this paper
• Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia.

  2024cites this paper
• Determination of D-serine and D-alanine Tissue Levels in the Prefrontal Cortex and Hippocampus of Rats After a Single Dose of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, with Potential Antipsychotic and Antidepressant Properties

  2023cites this paper
• Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia

  2023cites this paper
• NRX-101, a Rapid-Acting Anti-Depressant, Does Not Cause Neurotoxicity Following Ketamine Administration in Preclinical Models

  2022cites this paper
• The glutamate/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: On the path from syndrome to disease.

  2022cites this paper
• Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics

  2022cites this paper
• Postmortem, in silico, and clinical studies focused on perturbations of glutamate neurobiology in schizophrenia.

  2022cites this paper
• The mGlu7 receptor in schizophrenia - An update and future perspectives.

  2022cites this paper
• NMDA Receptor C-Terminal Domain Signalling in Development, Maturity, and Disease

  2022cites this paper
• MMN and P3a Elicited by a Novelty Oddball Paradigm Are Not Reduced in Early-Phase Psychosis

  2022cites this paper
• [18F]ALX5406: A Brain-Penetrating Prodrug for GlyT1-Specific PET Imaging.

  2021cites this paper
• Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials

  2021cites this paper
• An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data

  2021cites this paper
• Molecular mechanism of hippocampal long-term potentiation - Towards multiscale understanding of learning and memory.

  2021cites this paper
• Candidate Strategies for Development of a Rapid-Acting Antidepressant Class That Does Not Result in Neuropsychiatric Adverse Effects: Prevention of Ketamine-Induced Neuropsychiatric Adverse Reactions

  2020cites this paper
• Glutamate Level’s in Blood Serum of Patients with Schisophrenic Spectrum and Bipolar Affective Disorder

  2020cites this paper
• Repeated phencyclidine disrupts nicotinic acetylcholine regulation of dopamine release in nucleus accumbens: implications for models of schizophrenia.

  2020cites this paper
• Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery

  2020cites this paper
• Interaction between Mesocortical and Mesothalamic Catecholaminergic Transmissions Associated with NMDA Receptor in the Locus Coeruleus

  2020cites this paper
• Глутамат в сыворотке крови больных с расстройствами шизофренического спектра и биполярным аффективным расстройством

  2020cites this paper
• Effects of combined 5-HT2A and cannabinoid receptor modulation on a schizophrenia-related prepulse inhibition deficit in mice

  2020cites this paper
• Psychoses

  2019cites this paper
• Glutamate hypothesis in schizophrenia

  2019influential citation
• Characteristics of the effects of genetic variation in rodent models of risk for schizophrenia and neurodevelopment disorder

  2019cites this paper
• Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus

  2019cites this paper
• Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.

  2019cites this paper
• Pharmacological Discrimination of Effects of MK801 on Thalamocortical, Mesothalamic, and Mesocortical Transmissions

  2019cites this paper
• Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT1A Receptor with 5-HT3 Receptor Inhibition in Rats

  2019cites this paper
• Glutamate modulators for treatment of schizophrenia

  2019cites this paper
• Parvalbumin Interneuron Damage Plays a Central Role in the Pathogenesis of Schizophrenia

  2019influential citation
• Histamine H3 receptor activation reduces the impairment in prepulse inhibition (PPI) of the acoustic startle response and Akt phosphorylation induced by MK-801 (dizocilpine), antagonist at N-Methyl-d-Aspartate (NMDA) receptors.

  2019cites this paper
• Lurasidone inhibits NMDA receptor antagonist‐induced functional abnormality of thalamocortical glutamatergic transmission via 5‐HT7 receptor blockade

  2019cites this paper
• Simultaneous activation of muscarinic and GABAB receptors as a bidirectional target for novel antipsychotics

  2019cites this paper
• Personalized psychiatry with human iPSCs and neuronal reprogramming

  2019cites this paper
• Amantadine Combines Astroglial System Xc− Activation with Glutamate/NMDA Receptor Inhibition

  2019cites this paper
• Rat 50-kHz ultrasonic vocalizations as a tool in studying neurochemical mechanisms that regulate positive emotional states.

  2018cites this paper
• Distinctive Roles of D-Amino Acids in the Homochiral World: Chirality of Amino Acids Modulates Mammalian Physiology and Pathology.

  2018cites this paper
• Chronic administration of quetiapine attenuates the phencyclidine-induced recognition memory impairment and hippocampal oxidative stress in rats

  2018cites this paper
• Neurochemical changes underlying schizophrenia‐related behavior in a modified forced swim test in mice

  2018cites this paper
• Activation of mGluR 2 / 3 receptors in the ventral prefrontal cortex reverses sensorimotor gating deficits induced by a systemic NMDA receptor antagonist

  2018cites this paper
• Утицај антипсихотика на коштано ткиво и хипоталамо-хипофизно-адреналну осовину у фенциклидинском анималном моделу схизофреније

  2018cites this paper
• La phosphorylation du récepteur mGlu₂ du glutamate : mécanisme clé de son cross talk fonctionnel avec le récepteur 5-HT2A de la sérotonine

  2018cites this paper
• Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity

  2018cites this paper
• Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.

  2017cites this paper
• Classics in Chemical Neuroscience: Ketamine.

  2017cites this paper
• Dual Diagnosis as a Tool for Therapists and Social Workers

  2017cites this paper
• Comprehensive review: Computational modelling of schizophrenia.

  2017influential citation
• Why is pharma so scared of psychiatric drug discovery

  2017cites this paper
• Behavioural and molecular characterisation of mice haploinsufficient for Map2k7, a schizophrenia risk gene

  2017cites this paper
• From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors As a Potential Mechanistic Link

  2017cites this paper
• Genetic Basis of Positive and Negative Symptom Domains in Schizophrenia

  2017influential citation
• Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery

  2017cites this paper
• Biological function of D-aspartate in the mammalian brain

  2016influential citation
• Modeling psychiatric disorders with patient-derived iPSCs.

  2016cites this paper
• Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker

  2016cites this paper
• Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia.

  2016cites this paper
• Low d-serine levels in schizophrenia: A systematic review and meta-analysis.

  2016cites this paper
• Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment.

  2016cites this paper
• Curative Effect of Aqueous Leaf Extract of Crinum Giganteum on NMDA-Receptor Antagonist-Induced Schizophrenic Wistar Rat Model

  2016cites this paper
• Astroglia, Glutamatergic Transmission and Psychiatric Diseases.

  2016cites this paper
• Functional hierarchy underlies preferential connectivity disturbances in schizophrenia

  2015cites this paper
• Drug models of schizophrenia

  2015cites this paper
• [Role of astrocytes in alterations of glutamatergic neurotransmission in schizophrenia].

  2015cites this paper
• Overview of Glutamatergic Dysregulation in Central Pathologies

  2015cites this paper
• Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population

  2015cites this paper
• mGlu₅-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia.

  2015cites this paper
• Meeting overview: Sensory perception and schizophrenia, Lausanne, Switzerland June 31–July 1, 2014

  2015cites this paper
• Role of astrocytes in alterations of glutamatergic neurotransmission in schizophrenia

  2015cites this paper
• The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies

  2015cites this paper
• Allocentric spatial navigation impairment in schizophrenic subject: A model-based study

  2015influential citation
• Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development.

  2015cites this paper
• GlyT-1 Inhibitors: From Hits to Clinical Candidates

  2014cites this paper
• Computational study of NMDA conductance and cortical oscillations in schizophrenia

  2014influential citation
• Development of allosteric modulators of GPCRs for treatment of CNS disorders.

  2014cites this paper
• Partial genetic deletion of neuregulin 1 and adolescent stress interact to alter NMDA receptor binding in the medial prefrontal cortex

  2014influential citation
• Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor.

  2014cites this paper
• Is milnacipran a promising agent to suppress impulsive behavior

  2014cites this paper
• Therapeutic Advances in Psychopharmacology

  2014cites this paper
• Chronic phencyclidine treatment induces long-lasting glutamatergic activation of VTA dopamine neurons.

  2014cites this paper
• Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia.

  2014cites this paper
• Chronic Phencyclidine Induces Inflammatory Responses and Activates GSK3β in Mice

  2014cites this paper
• Mechanism based neurotoxicity of mGlu5 positive allosteric modulators--development challenges for a promising novel antipsychotic target.

  2014cites this paper
• Studying the effect of dysregulation of NMDA receptors function in schizophrenia

  2014cites this paper
• Positron emission tomography in CNS drug discovery and drug monitoring.

  2014cites this paper
• The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

  2014cites this paper
• Activation of mGluR2/3 receptors in the ventro-rostral prefrontal cortex reverses sensorimotor gating deficits induced by systemic NMDA receptor antagonists.

  2014cites this paper
• The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT1A signalling

  2013cites this paper
• Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats: a putative model of the negative symptoms of schizophrenia?

  2013influential citation
• Alternations of NMDA and GABAB Receptor Function in Development: A Potential Animal Model of Schizophrenia

  2013cites this paper
• The antipsychotic‐like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents

  2013cites this paper
• Mechanisms of glycine release, which build up synaptic and extrasynaptic glycine levels: the role of synaptic and non-synaptic glycine transporters.

  2013cites this paper
• Neurophysiological analysis of schizophrenia based on dysfunction of the glutamatergic system using a tripartite synapse model

  2013cites this paper
• A combined study of genetic association and brain imaging on the DAOA gene in schizophrenia

  2013cites this paper
• Amphiphysin I but not dynamin I nor synaptojanin mRNA expression increased after repeated methamphetamine administration in the rat cerebrum and cerebellum

  2013cites this paper
• Expression of presynaptic markers in a neurodevelopmental animal model with relevance to schizophrenia

  2013cites this paper
• Modulation of NMDA receptor function as a treatment for schizophrenia.

  2013cites this paper